German Pharma Stock News

Sartorius (XTRA:SRT3) is back in focus after expanding its bio circular product range, with additional German and Tunisian facilities now ISCC Plus certified to use renewable raw materials in several bioprocessing lines. See our latest analysis for Sartorius. That push into certified bio circular products comes as Sartorius trades at €254.4, with a 30 day share price return of 5.96% and a 1 year total shareholder return of 5.69%, set against a 3 year total shareholder return decline of 36.31%...

As the European markets show resilience with the STOXX Europe 600 Index rising by 0.77%, investors are keenly observing growth opportunities amid mixed performances across major indices. In this environment, companies with strong insider ownership often attract attention, as insiders' stakes can signal confidence in long-term prospects and align interests with shareholders.

The European market has shown resilience, with the STOXX Europe 600 Index ending higher, buoyed by robust economic data and mixed earnings results across major stock indexes. Amid this backdrop, the concept of penny stocks remains pertinent as these smaller or newer companies can offer unique growth opportunities. While the term might seem outdated, penny stocks continue to capture investor interest due to their potential for significant returns when backed by strong financials and fundamentals.

Key Insights Using the 2 Stage Free Cash Flow to Equity, Friedrich Vorwerk Group fair value estimate is €88.28 Current...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Long term investing works well, but it doesn't always work for each individual stock. We really hate to see fellow...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Continental fair value estimate is €112 Current share price of...

With a price-to-sales (or "P/S") ratio of 0.2x DEAG Deutsche Entertainment Aktiengesellschaft ( HMSE:LOU ) may be...

With a price-to-earnings (or "P/E") ratio of 3.7x Francotyp-Postalia Holding AG ( HMSE:FPH ) may be sending very...

Most readers would already be aware that Jenoptik's (ETR:JEN) stock increased significantly by 16% over the past month...

RTL Group S.A.'s ( ETR:RRTL ) price-to-earnings (or "P/E") ratio of 22.9x might make it look like a sell right now...

For many, the main point of investing is to generate higher returns than the overall market. But the main game is to...

Key Insights Nemetschek's estimated fair value is €117 based on 2 Stage Free Cash Flow to Equity Current share price of...

Stabilus SE ( ETR:STM ) has announced that on 9th of February, it will be paying a dividend of€0.35, which a reduction...

Carl Zeiss Meditec (XTRA:AFX) is set to engage investors at the 25th German Corporate Conference in Frankfurt, where its CFO and Investor Relations head plan to discuss the business and address market questions. See our latest analysis for Carl Zeiss Meditec. At a share price of €39.44, Carl Zeiss Meditec has seen pressure on momentum, with a 90 day share price return of a 17.35% decline and a 1 year total shareholder return of a 17.28% loss, so investors will be watching the conference for...

If you are wondering whether Deutsche Bank's current share price gives you good value for your money, you are not alone. This article focuses squarely on what you might be paying for each euro of underlying business. After a 1.5% move over the last week, 1.8% over the past month, flat year to date and an 86.2% return over the past year, Deutsche Bank's share price invites a closer look at what is baked into expectations. Recent coverage has highlighted Deutsche Bank's ongoing efforts to...

Sales update puts Redcare Pharmacy in focus Redcare Pharmacy (XTRA:RDC) is back on investors’ radar after reporting fourth quarter 2025 group sales of €794 million, compared with €675 million a year earlier, alongside full year sales of €2.9b versus €2.4b in 2024. See our latest analysis for Redcare Pharmacy. Despite the strong sales update, Redcare Pharmacy’s share price has had a weak run, with a 90 day share price return of 24.46% decline and a 1 year total shareholder return of 45.89%...

While CTS Eventim AG & Co. KGaA ( ETR:EVD ) might not have the largest market cap around , it saw significant share...

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

BRAIN Biotech AG ( ETR:BNN ) is possibly approaching a major achievement in its business, so we would like to shine...

With a price-to-earnings (or "P/E") ratio of 37.2x Knorr-Bremse AG ( ETR:KBX ) may be sending very bearish signals at...

Investing in stocks inevitably means buying into some companies that perform poorly. Long term PNE AG ( ETR:PNE3...